Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

Stopped early

Conditions studied: Central Nervous System Neoplasms

In brief

This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.

Key facts

Study ID
NCT02095353
Run by
University of Nebraska
People needed
6
Starts
2014-09-01
Expected to finish
2017-03-07
Last updated by the study team
2023-08-23

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.